Home
News
Create
Screeners
Insights
Amanta Healthcare
105.
46
+0.82
(+0.78%)
Market Cap
₹409.49 Cr
PE Ratio
26.66
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.78%
1M
+2.18%
6M
-25.60%
1Y
-25.60%
5Y
-25.60%
View Company Insights
Latest news about Amanta Healthcare
Amanta Healthcare Hosts Maiden Earnings Call, Outlines ₹150 Crore Revenue Expansion Plan
Feb 11, 2026
Amanta Healthcare held its first earnings conference call following Q3FY26 results, with management detailing major expansion plans including doubling SteriPort capacity and SVP line enhancement. The company projects ₹150 crore incremental revenue from these initiatives, targeting overall revenue of ₹400 crore by FY27, while implementing cost optimization through a 10.8 MW solar plant expected to save ₹9 crore annually.
Amanta Healthcare Limited Announces Changes in Senior Management Personnel
Feb 10, 2026
Amanta Healthcare Opens Special Window for Transfer and Dematerialisation of Physical Securities
Feb 02, 2026
Amanta Healthcare Corrects Solar Power Plant Capacity to 10.8 MWp in Revised Agreement
Dec 30, 2025
Amanta Healthcare Allocates Rs 3,030 Crore from IPO Proceeds for Expansion
Nov 14, 2025
More news about Amanta Healthcare
12
Nov 25
Amanta Healthcare Reports Fund Utilization Deviation and Q2 FY2026 Financial Results
Amanta Healthcare Limited disclosed a deviation in IPO fund utilization due to GST payment changes, adjusting issue expenses and reducing general corporate purpose expenses. The company's Q2 FY2026 results show revenue growth to Rs. 7,088.73 lakhs, but a decrease in net profit to Rs. 120.75 lakhs compared to Q2 FY2025. Half-year performance improved with revenue at Rs. 13,619.44 lakhs and net profit at Rs. 471.47 lakhs. Balance sheet highlights include increased total assets of Rs. 48,831.55 lakhs and improved cash position of Rs. 9,196.41 lakhs as of September 30, 2025.
12
Nov 25
Amanta Healthcare Reports Q2 Profit, Completes IPO Listing
Amanta Healthcare Limited reported Q2 FY2026 results with total income of Rs. 7,095.80 lakhs and net profit of Rs. 207.80 lakhs. For H1 FY2026, total income was Rs. 13,850.45 lakhs with net profit of Rs. 185.50 lakhs. The company completed its IPO, issuing 10 million shares at Rs. 126 each, raising Rs. 12,600 lakhs. Listing occurred on September 9, 2025, on BSE and NSE. IPO proceeds are allocated for new manufacturing lines and corporate purposes, with Rs. 3,030.02 lakhs utilized so far. PriceWaterhouseCoopers provided an unmodified review opinion on the financial results.
Amanta Healthcare
105.
46
+
0.
82
(+
0.
78
%)
1 Year Returns:
-25.60%
Industry Peers
Sun Pharmaceutical
1,724.40
(+
0.
64
%)
Divis Laboratories
6,291.00
(-
0.
10
%)
Torrent Pharmaceuticals
4,241.70
(+
0.
36
%)
Cipla
1,341.10
(+
0.
92
%)
Dr Reddys Laboratories
1,280.40
(-
0.
15
%)
Lupin
2,219.40
(-
0.
42
%)
Zydus Life Science
900.75
(-
0.
18
%)
Mankind Pharma
2,024.30
(-
0.
75
%)
Aurobindo Pharma
1,158.80
(-
1.
08
%)
Alkem Laboratories
5,392.00
(+
0.
28
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation